Based on the provided data, the forecast for Respiratory System Medicine use in South Korea is expected to increase steadily from 92.2 units per thousand persons per day in 2024 to 96.4 units in 2028. Year-on-year variation shows an average growth rate of approximately 1.08% from 2024 to 2025, 1.18% from 2025 to 2026, 1.06% from 2026 to 2027, and 1.15% from 2027 to 2028, indicating consistent and gradual growth. This data represents a compound annual growth rate (CAGR) of 1.12% over the five-year forecast period.
Future trends to watch for include advancements in respiratory treatment technologies, potential increases in respiratory diseases due to environmental factors, and changes in healthcare policies that may affect medicine availability and usage. Additionally, monitoring demographic shifts such as aging populations will be crucial in understanding demand dynamics in respiratory medicine.
